A detailed history of Zrc Wealth Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Zrc Wealth Management, LLC holds 58 shares of BIIB stock, worth $10,079. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58
Previous 58 -0.0%
Holding current value
$10,079
Previous $13.4 Million 16.38%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

BUY
$212.02 - $267.71 $5,936 - $7,495
28 Added 93.33%
58 $12.5 Million
Q1 2023

May 04, 2023

BUY
$256.56 - $292.34 $7,696 - $8,770
30 New
30 $8.34 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Zrc Wealth Management, LLC Portfolio

Follow Zrc Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zrc Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zrc Wealth Management, LLC with notifications on news.